Potential antiprostatic performance of novel lanthanide-complexes based on 5-nitropicolinic acid
JBIC Journal of Biological Inorganic Chemistry · 2024
DOI: 10.1007/s00775-024-02054-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift JBIC Journal of Biological Inorganic Chemistry, 2024. Verfasst von Amalia García-García und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Inorganic Chemistry, Faculty of Science, University of Granada, Av. Fuente Nueva S/N, 18071, Granada, Spain. Hauptthemen laut MEDLINE: Lanthanoid Series Elements, Picolinic Acids, Antineoplastic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union, Consejería de Economía, Innovación, Ciencia y Empleo, Junta de Andalucía, Ministerio de Ciencia e Innovación.
Abstract (Originalsprache)
Two new lanthanide-complexes based on the 5-nitropicolinate ligand (5-npic) were obtained and fully characterized. Single-crystal X-ray diffraction revealed that these compounds are isostructural to a Dy-complex, previously published by us, based on dinuclear monomers link together with an extended hydrogen bond network, providing a final chemical formula of [Ln 2 (5-npic) 6 (H 2 O) 4 ]·(H 2 O) 2 , where Ln = Dy (1) , Gd (2) , and Tb (3) . Preliminary photoluminescent studies exhibited a ligand-centered emission for all complexes. The potential antitumoral activity of these materials was assayed in a prostatic cancer cell line (PC-3; the 2nd most common male cancerous disease), showing a significant anticancer activity (50–60% at 500 μg·mL −1 ). In turn, a high biocompatibility by both, the complexes and their precursors in human immunological HL-60 cells, was evidenced. In view of the strongest toxic effect in the tumoral cell line provided by the free 5-npic ligand (~ 40–50%), the overall anticancer complex performance seems to be triggered by the presence of this molecule. Graphical Abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Inorganic Chemistry, Faculty of Science, University of Granada, Av. Fuente Nueva S/N, 18071, Granada, Spain.
- Advanced Porous Material Unit, IMDEA Energy Institute, Av. Ramón de La Sagra 3, 28935, Móstoles, Madrid, Spain.
- Advanced Porous Material Unit, IMDEA Energy Institute, Av. Ramón de La Sagra 3, 28935, Móstoles, Madrid, Spain. patricia.horcajada@imdea.org.
- Department of Inorganic Chemistry, Faculty of Science, University of Granada, Av. Fuente Nueva S/N, 18071, Granada, Spain. srojas@ugr.es.
Förderung
- European Union
- Consejería de Economía, Innovación, Ciencia y Empleo, Junta de Andalucía
- Ministerio de Ciencia e Innovación
- Universidad de Granada
Zitieren
APA
García-García, A., Cristobal-Cueto, P., Hidalgo, T., Vitórica-Yrezábal, I. J., Rodríguez-Diéguez, A., Horcajada, P., & Rojas, S. (2024). Potential antiprostatic performance of novel lanthanide-complexes based on 5-nitropicolinic acid. JBIC Journal of Biological Inorganic Chemistry. https://doi.org/10.1007/s00775-024-02054-0
Vancouver
García-García A, Cristobal-Cueto P, Hidalgo T, Vitórica-Yrezábal IJ, Rodríguez-Diéguez A, Horcajada P, et al. Potential antiprostatic performance of novel lanthanide-complexes based on 5-nitropicolinic acid. JBIC Journal of Biological Inorganic Chemistry. 2024. doi:10.1007/s00775-024-02054-0
BibTeX
@article{GarcaGarca2024,
author = {García-García, Amalia and Cristobal-Cueto, Pablo and Hidalgo, Tania and Vitórica-Yrezábal, Iñigo J and Rodríguez-Diéguez, Antonio and Horcajada, Patricia and Rojas, Sara},
title = {Potential antiprostatic performance of novel lanthanide-complexes based on 5-nitropicolinic acid},
journal = {JBIC Journal of Biological Inorganic Chemistry},
year = {2024},
doi = {10.1007/s00775-024-02054-0}
}
EUVIMED